Pharmacy Medical News about Economics, Pharmaceutical

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI
Value in Health, 10/29/09

Shi L et al. – CEA researchers conducting international pharmacoeconomic analysis should tailor the appropriate measure of drug costs to the international perspective, to maintain clarity and transparency on drug cost measurement in the context of international drug comparison and report the sensitivity of CEA results to reasonable cost conversions.

<< Previous
Good Research Practices for Measuring Drug Costs in Cost...

Next >>
The Impact of Fewer Hip Fractures with Risedronate Versus...

Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
PharmacoEconomics, 10/07/09 Relevance Score: 67%

30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement
PharmacoEconomics, 10/13/09 Relevance Score: 66%

Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings
Health Policy and Planning, 10/21/09 Relevance Score: 65%

Financial Risk of the Biotech Industry versus the Pharmaceutical Industry
Applied Health Economics and Health Policy, 10/20/09 Relevance Score: 64%

Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide
PharmacoEconomics, 10/13/09 Relevance Score: 64%